共 50 条
Advances in food allergy oral immunotherapy: toward tolerance
被引:20
|作者:
Freeland, Deborah M. Hussey
[1
]
Fan-Minogue, Hua
[1
]
Spergel, Jonathan M.
[2
,3
]
Chatila, Talal A.
[4
,5
]
Nadeau, Kari C.
[1
]
机构:
[1] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA
[2] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA
[4] Boston Childrens Hosp, Div Immunol, Boston, MA USA
[5] Harvard Med Sch, Dept Pediat, Boston, MA USA
关键词:
DOUBLE-BLIND;
ANAPHYLAXIS;
OMALIZUMAB;
FUTURE;
SAFETY;
D O I:
10.1016/j.coi.2016.08.002
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The incidence of food allergy, a disease characterized by adverse immune responses that can render common foods life threatening, is rising. Yet our current standard of care is simply avoidance of allergenic foods and administration of emergency medications upon accidental exposure. Significant advances have been made in food allergy oral immunotherapy, which is emerging as a potential preventive and curative treatment for this disease. The fundamental strategy of oral immunotherapy is to mitigate adverse immune responses to allergenic food proteins through repeated exposure; reduced reactivity to food allergens (desensitization) often results, but the establishment of sustained immune unresponsiveness or of permanent resolution (tolerance) is not certain. This review examines exciting recent developments in oral immunotherapy for food allergy.
引用
收藏
页码:119 / 123
页数:5
相关论文